Magazine article from our research archive:
|
|
Rituxan warning.(Updates)(side effect of the drug Rituxan)(Brief article)
- Article from:
-
FDA Consumer
- Article date:
-
March 1, 2007
|
Copyright informationCOPYRIGHT 2007 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The FDA recently learned that two patients who were treated with Rituxan (rituximab) for systemic lupus erythematosus (SLE) developed progressive multifocal leukoencephalopathy (PML), a fatal viral infection of the central nervous system. This side effect has been reported in patients as late as 12 months after their last dose of Rituxan.
SLE is not an approved indication for Rituxan. The drug is approved only for the treatment of people with non-Hodgkin's lymphoma and people with rheumatoid arthritis whose disease no longer responds to other common treatments. Rituxan acts on the body's immune system by decreasing certain types of white blood cells. This factor makes the ...
|
Cancer Drug Gets New-Use Approval; Rituxan Can Treat Rheumatoid Arthritis
The Washington Post;
March 1, 2006 ;
Justin Gillis;
787 words
......different disease, rheumatoid arthritis, in a development...biology. The drug, Rituxan, is among a new...multibillion-dollar sales. Rituxan, which sells...treatment. Sales for rheumatoid arthritis are likely to...control a case of rheumatoid arthritis that was ...
|
|
TYSABRI FOCUS OBSCURES ANOTHER BIOGEN IDEC ADVANCE TYSBARI WATCH TAKES...
The Boston Globe;
March 6, 2006 ;
Jeffrey Krasner, Globe Staff;
688 words
......Medical Center. Rituxan uses a different...than existing rheumatoid arthritis treatments...suffer from rheumatoid arthritis, Rituxan will be targeted...movement of Rituxan into the [rheumatoid arthritis] setting will...
|
 "The News & Record (Piedmont Triad, NC)")
|
MANAGEMENT OF RHEUMATOID ARTHRITIS.(TRIAD)
The News & Record (Piedmont Triad, NC);
May 24, 2005 ;
Gay, Robert M.;
605 words
......Special to the News & Record Rheumatoid arthritis (RA) is a relatively common disease...tissues and lead to disability. Rheumatoid arthritis affects women twice as often as...ages of 40 and 60. The cause of rheumatoid arthritis is not fully understood. In some...
|
|
Diagnosing rheumatoid arthritis: current criteria.
American Family Physician;
September 1, 1991 ;
Smith, Carolyn A. Arnett, Frank C., Jr.;
787 words
...Rheumatoid arthritis is a chronic, systemic inflammatory...and mortality. Historically, rheumatoid arthritis may have developed recently...at the Salpetriere; the term rheumatoid arthritis was coined by Garrod in 1858...
|
|
Biogen Idec and Genentech Submit a Supplemental Biologics License...
PR Newswire;
August 31, 2005 ;
787 words
......for a new indication for Rituxan(R) (Rituximab) in patients with active rheumatoid arthritis (RA) who inadequately respond...course of two infusions of Rituxan with a stable dose of methotrexate...pleased to be submitting these Rituxan RA data to the FDA and will...development, Biogen Idec. ...
|
|
|
Positive Data from Preliminary Phase II Study of Rituxan(R) in Rheumatoid...
PR Newswire;
June 16, 2004 ;
787 words
......showing that two doses of Rituxan(R) (Rituximab), administered...with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks...receiving the combination of Rituxan with MTX and a brief course...play a central role in rheumatoid arthritis and suggests that B-lymphocyte...with ...
|
|
Economy, effects and efficacy all keys to market success of Rheumatoid...
M2 Presswire;
August 4, 2004 ;
787 words
......effects and efficacy all keys to market success of Rheumatoid Arthritis drugs(C)1994-2004 M2 COMMUNICATIONS LTD RDATE:08042004...London - Like the disease itself, the market for Rheumatoid Arthritis (RA) medication is a difficult one to penetrate...Datamonitor healthcare analyst Clare Churchill ...
|
|
|
Phase III Study Shows Rituxan(R) Significantly Improves Symptoms in...
PR Newswire;
April 6, 2005 ;
787 words
......Phase III clinical study of Rituxan(R) (Rituximab) met its primary...a greater proportion of Rituxan-treated patients achieving...included patients with active rheumatoid arthritis (RA) who have had an inadequate...course of two infusions of Rituxan with a stable dose of ...
|
|
|
New treatment strategies for rheumatoid arthritis.(Tips from Other...
American Family Physician;
September 15, 1997 ;
Sadovsky, Richard;
489 words
...Rheumatoid arthritis is a severe, progressive disease...The objective of therapy for rheumatoid arthritis is to relieve pain, reduce...understanding of the etiology of rheumatoid arthritis and the new strategies and...
|
|
|
Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent...
PR Newswire;
September 5, 2008 ;
787 words
......announced today that it presented new rheumatoid arthritis data at the Marcus Evans conference...CEL-SCI, indicate that CEL-SCI's rheumatoid arthritis vaccine CEL-2000 prevents or retards...permanent tissue damage caused by rheumatoid arthritis in an animal model of the disease...
|
|
|
Biogen Idec and Genentech Announce FDA Acceptance of Supplemental...
PR Newswire;
October 31, 2005 ;
787 words
......submitted by the companies for Rituxan(R) (Rituximab) for patients with active rheumatoid arthritis (RA) who inadequately respond...2006, to take action on the Rituxan sBLA submission. The companies...course of two infusions of Rituxan with a stable dose of methotrexate...common side ...
|
|
Leading Rheumatologists Agree Clinical Remission a Key Goal in Rheumatoid...
PR Newswire Europe;
March 17, 2008 ;
787 words
......importance of early intervention in rheumatoid arthritis to achieve clinical remission, a...the disease. In the first major rheumatoid arthritis trial to use clinical remission...less than two years of early active rheumatoid arthritis who received a combination of Enbrel...
|
See all results.
Or, try our
Advanced Search.
|